(Q44623740)

4 December 2017

title

Hepatic artery chemoembolization in 122 patients with metastatic carcinoid tumor: lessons learned (English)

1 reference

4 December 2017

1 reference

1 reference

Mark Bloomston

1

1 reference

4 December 2017

Osama Al-Saif

2

1 reference

4 December 2017

Dori Klemanski

3

1 reference

4 December 2017

Joseph J Pinzone

4

1 reference

4 December 2017

Edward W Martin

5

1 reference

4 December 2017

Bryan Palmer

6

1 reference

4 December 2017

Gregory Guy

7

1 reference

4 December 2017

Hooman Khabiri

8

1 reference

4 December 2017

E Christopher Ellison

9

1 reference

4 December 2017

Manisha H Shah

10

1 reference

4 December 2017

language of work or name

1 reference

1 March 2007

1 reference

Journal of Gastrointestinal Surgery

4 December 2017

published in

1 reference

4 December 2017

volume

11

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

264-271

1 reference

https://scigraph.springernature.com/pub.10.1007/s11605-007-0089-z

4 December 2017

exact match

0 references

cites work

Serum peptide profiles in patients with carcinoid tumors

1 reference

12 December 2020

Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase II study in 24 patients.

1 reference

12 December 2020

Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma

1 reference

12 December 2020

Hepatic surgery for metastases from neuroendocrine tumors

1 reference

12 December 2020

An analysis of 8305 cases of carcinoid tumors

1 reference

12 December 2020

Hepatic artery embolization and chemoembolization for treatment of patients with metastatic carcinoid tumors: the M.D. Anderson experience

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Serum pancreastatin levels predict response to hepatic artery chemoembolization and somatostatin analogue therapy in metastatic neuroendocrine tumors

1 reference

12 December 2020

Evaluation of temporary liver dearterialization and embolization in patients with metastatic carcinoid tumour

1 reference

12 December 2020

Measurement of quality of life in carcinoid/neuroendocrine tumours.

1 reference

12 December 2020

Immunohistochemical Localization of Chromostatin and Pancreastatin, Chromogranin A-Derived Bioactive Peptides, in Normal and Neoplastic Neuroendocrine Tissues

1 reference

12 December 2020

The ultimate biochemical diagnosis of gastro-enteropancreatic tumours

1 reference

12 December 2020

Treatment of neuroendocrine cancer metastatic to the liver: the role of ablative techniques.

1 reference

12 December 2020

Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors

1 reference

12 December 2020

Improved outcome with cytoreduction versus embolization for symptomatic hepatic metastases of carcinoid and neuroendocrine tumors

1 reference

12 December 2020

A 5-decade analysis of 13,715 carcinoid tumors

1 reference

12 December 2020

Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors

1 reference

12 December 2020

Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours

1 reference

12 December 2020

Hepatic arterial chemoembolization for metastatic neuroendocrine tumors

1 reference

12 December 2020

Indications and results of liver resection and hepatic chemoembolization for metastatic gastrointestinal neuroendocrine tumors

1 reference

12 December 2020

Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms

1 reference

12 December 2020

Treatment of metastatic carcinoid tumors using multimodality therapy of octreotide acetate, intra-arterial chemotherapy, and hepatic arterial chemoembolization

1 reference

12 December 2020

Hepatic artery chemoembolization or embolization for primary and metastatic liver tumors: post-treatment management and complications

1 reference

12 December 2020

Surgical treatment of advanced-stage carcinoid tumors: lessons learned

1 reference

12 December 2020

Chemoembolization and other ablative therapies for liver metastases of gastrointestinal endocrine tumours

1 reference

12 December 2020

Hepatic neuroendocrine metastases: does intervention alter outcomes?

1 reference

12 December 2020

Prognosis and survival in patients with gastrointestinal tract carcinoid tumors

1 reference

12 December 2020

Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival

1 reference

12 December 2020

Selective hepatic artery embolization for treatment of patients with metastatic carcinoid and pancreatic endocrine tumors

1 reference

12 December 2020

10.1007/S11605-007-0089-Z

Identifiers

DOI

1 reference

4 December 2017

1 reference